Secukinumab for Psoriasis in Obese Patients: Minireview and Clinical Experience

Psoriasis (PsO) has been associated with obesity, and its severity increases in obese subjects. The link between psoriatic condition and obesity is based on shared pathophysiological pathways where local and systemic inflammation promote each other; PsO is an inflammatory, immune-mediated disease, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiberio, Rossana, Graziola, Francesca, Miglino, Benedetta, Veronese, Federica, Annali, Giordana, Savoia, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case and Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816128/
https://www.ncbi.nlm.nih.gov/pubmed/31662736
http://dx.doi.org/10.1159/000501990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816128/
https://www.ncbi.nlm.nih.gov/pubmed/31662736
http://dx.doi.org/10.1159/000501990

Ejemplares similares